Larvol Delta - Continuous-infusion-therapy-after-deep-brain-stimulation-in-Parkinson39s-disease-indications-outcomes-and-patient-selection

BI 1701963 - Boehringer Ingelheim

Mekinist (trametinib) - Novartis, BeOne Medicines

http://clinicaltrials.gov/ct2/show/NCT04111458

Sep 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next